Abeona Gene Therapy Gains FDA Regenerative Medicine Designation – Pharmaceutical Processing
|
Abeona Gene Therapy Gains FDA Regenerative Medicine Designation
Pharmaceutical Processing Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, announced that the U.S. Food and Drug Administration (FDA) has granted the … |
